2024 Q2 Form 10-Q Financial Statement

#000139297224000063 Filed on May 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $82.01M $80.69M $73.18M
YoY Change 8.21% 10.26% 10.06%
Cost Of Revenue $28.82M $28.83M $29.54M
YoY Change 0.87% -2.4% 7.97%
Gross Profit $53.19M $51.86M $43.64M
YoY Change 12.65% 18.82% 11.52%
Gross Profit Margin 64.86% 64.27% 59.63%
Selling, General & Admin $38.59M $37.74M $40.15M
YoY Change -0.35% -5.98% 1.34%
% of Gross Profit 72.55% 72.79% 91.99%
Research & Development $21.79M $24.41M $22.29M
YoY Change -0.28% 9.52% -8.89%
% of Gross Profit 40.96% 47.08% 51.08%
Depreciation & Amortization $2.191M $2.204M $3.001M
YoY Change -20.36% -26.56% -35.42%
% of Gross Profit 4.12% 4.25% 6.88%
Operating Expenses $60.38M $62.16M $62.44M
YoY Change -0.33% -0.45% -2.57%
Operating Profit -$7.184M -$10.30M -$18.80M
YoY Change -46.21% -45.19% -29.08%
Interest Expense $1.556M $1.762M -$1.576M
YoY Change -198.73% -211.8% 0.0%
% of Operating Profit
Other Income/Expense, Net $1.323M $458.0K $1.451M
YoY Change -26.13% -68.44% -447.13%
Pretax Income -$7.009M -$11.05M -$18.92M
YoY Change -46.66% -41.62% -33.6%
Income Tax $377.0K $311.0K $81.00K
% Of Pretax Income
Net Earnings -$7.386M -$11.36M -$19.00M
YoY Change -44.42% -40.23% -33.65%
Net Earnings / Revenue -9.01% -14.08% -25.97%
Basic Earnings Per Share -$0.16 -$0.24 -$0.41
Diluted Earnings Per Share -$0.16 -$0.24 -$0.41
COMMON SHARES
Basic Shares Outstanding 47.00M shares 46.74M shares 45.87M shares
Diluted Shares Outstanding 47.07M shares 46.82M shares 45.93M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $139.1M $156.4M $192.4M
YoY Change -24.64% -18.69% -11.51%
Cash & Equivalents $139.1M $156.4M $192.4M
Short-Term Investments
Other Short-Term Assets $16.25M $15.45M $18.58M
YoY Change -7.85% -16.85% 11.93%
Inventory
Prepaid Expenses
Receivables $47.71M $51.04M $45.79M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $203.0M $222.9M $256.7M
YoY Change -20.8% -13.18% -10.48%
LONG-TERM ASSETS
Property, Plant & Equipment $20.89M $21.57M $25.44M
YoY Change -46.03% -15.21% -9.59%
Goodwill $107.6M $107.6M $107.7M
YoY Change -0.14% -0.07% -0.2%
Intangibles $9.078M $10.38M $16.05M
YoY Change -37.07% -35.32% -34.89%
Long-Term Investments
YoY Change
Other Assets $9.503M $9.666M $8.872M
YoY Change -43.24% 8.95% 9.27%
Total Long-Term Assets $181.9M $185.0M $180.8M
YoY Change 2.39% 2.31% -9.51%
TOTAL ASSETS
Total Short-Term Assets $203.0M $222.9M $256.7M
Total Long-Term Assets $181.9M $185.0M $180.8M
Total Assets $384.9M $407.9M $437.6M
YoY Change -11.31% -6.78% -10.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.992M $2.535M $4.197M
YoY Change 1.72% -39.6% -47.25%
Accrued Expenses $14.76M $14.99M $13.36M
YoY Change -61.92% 12.2% 7.81%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $21.70M
YoY Change -100.0%
Total Short-Term Liabilities $166.9M $188.9M $160.8M
YoY Change -45.29% 17.44% -2.08%
LONG-TERM LIABILITIES
Long-Term Debt $271.6M $271.9M $290.2M
YoY Change 84.08% -6.28% 0.52%
Other Long-Term Liabilities $1.182M $1.191M $1.247M
YoY Change -96.41% -4.49% 5.5%
Total Long-Term Liabilities $1.182M $1.191M $1.247M
YoY Change -99.34% -4.49% 5.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $166.9M $188.9M $160.8M
Total Long-Term Liabilities $1.182M $1.191M $1.247M
Total Liabilities $467.9M $491.9M $485.5M
YoY Change -3.6% 1.31% -2.78%
SHAREHOLDERS EQUITY
Retained Earnings -$666.0M -$658.6M -$609.9M
YoY Change 6.87% 7.99% 13.51%
Common Stock $52.00K $52.00K $51.00K
YoY Change 1.96% 1.96% 2.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $29.85M $29.85M $29.85M
YoY Change 0.0% 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity -$83.04M -$84.02M -$47.97M
YoY Change
Total Liabilities & Shareholders Equity $384.9M $407.9M $437.6M
YoY Change -11.31% -6.78% -10.08%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$7.386M -$11.36M -$19.00M
YoY Change -44.42% -40.23% -33.65%
Depreciation, Depletion And Amortization $2.191M $2.204M $3.001M
YoY Change -20.36% -26.56% -35.42%
Cash From Operating Activities $6.420M -$4.644M -$6.143M
YoY Change -198.14% -24.4% -44.23%
INVESTING ACTIVITIES
Capital Expenditures $256.0K $223.0K $1.546M
YoY Change -7.58% -85.58% 235.36%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$113.0K
YoY Change
Cash From Investing Activities -$256.0K -$353.0K -$1.546M
YoY Change -7.58% -77.17% 235.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -23.54M -$7.314M -$3.573M
YoY Change 2356.78% 104.7% -390.25%
NET CHANGE
Cash From Operating Activities 6.420M -$4.644M -$6.143M
Cash From Investing Activities -256.0K -$353.0K -$1.546M
Cash From Financing Activities -23.54M -$7.314M -$3.573M
Net Change In Cash -17.37M -$12.32M -$11.25M
YoY Change 123.38% 9.54% 10.74%
FREE CASH FLOW
Cash From Operating Activities $6.420M -$4.644M -$6.143M
Capital Expenditures $256.0K $223.0K $1.546M
Free Cash Flow $6.164M -$4.867M -$7.689M
YoY Change -190.39% -36.7% -32.99%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
80688000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
73182000 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
28833000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
29542000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
51855000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
43640000 usd
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
22682000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
26010000 usd
CY2024Q1 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
24413000 usd
CY2023Q1 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
22291000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15062000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14135000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-10302000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-18796000 usd
CY2024Q1 pro Convertibledebtinterestandamortization
Convertibledebtinterestandamortization
1202000 usd
CY2023Q1 pro Convertibledebtinterestandamortization
Convertibledebtinterestandamortization
1576000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
458000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1451000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11046000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18921000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
311000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
81000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-11357000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-19002000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Outstanding Limited Partnership And General Partnership Unit Basic And Diluted
IncomeLossFromContinuingOperationsPerOutstandingLimitedPartnershipAndGeneralPartnershipUnitBasicAndDiluted
-0.24
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Outstanding Limited Partnership And General Partnership Unit Basic And Diluted
IncomeLossFromContinuingOperationsPerOutstandingLimitedPartnershipAndGeneralPartnershipUnitBasicAndDiluted
-0.41
CY2024Q1 us-gaap Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted
WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted
46817000 shares
CY2023Q1 us-gaap Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted
WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted
45926000 shares
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-173000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
176000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-173000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
176000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11530000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18826000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-11357000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-19002000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2204000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3001000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
-284000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
373000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
12700000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
9904000 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
149000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
108000 usd
CY2024Q1 pro Gain On Lease Modification
GainOnLeaseModification
697000 usd
CY2023Q1 pro Gain On Lease Modification
GainOnLeaseModification
0 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-774000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-35000 usd
CY2024Q1 pro Accounts And Unbilled Receivables
AccountsAndUnbilledReceivables
2098000 usd
CY2023Q1 pro Accounts And Unbilled Receivables
AccountsAndUnbilledReceivables
-2239000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-606000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-425000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1070000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2505000 usd
CY2024Q1 us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
848000 usd
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
591000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-637000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3793000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2327000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
504000 usd
CY2024Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-16611000 usd
CY2023Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-8174000 usd
CY2024Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
8058000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
11333000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4644000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6143000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
223000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1546000 usd
CY2024Q1 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
17000 usd
CY2023Q1 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
0 usd
CY2024Q1 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
113000 usd
CY2023Q1 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-353000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1546000 usd
CY2024Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1024000 usd
CY2023Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1137000 usd
CY2024Q1 pro Tax Withholding Related To Net Share Settlement Of Restricted Stock Units
TaxWithholdingRelatedToNetShareSettlementOfRestrictedStockUnits
8338000 usd
CY2023Q1 pro Tax Withholding Related To Net Share Settlement Of Restricted Stock Units
TaxWithholdingRelatedToNetShareSettlementOfRestrictedStockUnits
4710000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-7314000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3573000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-13000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12324000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-11251000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
178747000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
203627000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
166423000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
192376000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
156423000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
192376000 usd
CY2024Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
10000000 usd
CY2023Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
0 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
166423000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
192376000 usd
CY2024Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
119000 usd
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
136000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-77873000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-8338000 usd
CY2024Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1024000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12700000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-173000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-11357000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-84017000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-35473000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-4710000 usd
CY2023Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1137000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9904000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
176000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-19002000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-47968000 usd
CY2024Q1 us-gaap Nature Of Operations
NatureOfOperations
Organization and Nature of Operations<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PROS Holdings, Inc., a Delaware corporation, through its operating subsidiaries (collectively, the "Company"), provides solutions that optimize shopping and selling experiences. PROS solutions leverage artificial intelligence ("AI"), self-learning and automation to ensure that every transactional experience is fast, frictionless and personalized for every shopper, supporting both business-to-business ("B2B") and business-to-consumer ("B2C") companies across industry verticals. Companies can use these selling, pricing, revenue optimization, distribution and retail, and digital offer marketing solutions to assess their market environments in real time to deliver customized prices and offers. The Company's solutions enable their customers to provide the buyers of their products the ability to move fluidly from one sales channel to another, whether direct, partner, online, mobile or other emerging channels, each with a personalized experience regardless of which channel is used. The Company's decades of data science and AI expertise are infused into its solutions and are designed to reduce time and complexity through actionable intelligence.</span></div>
CY2024Q1 pro Treasury Money Market Funds At Fair Value
TreasuryMoneyMarketFundsAtFairValue
150600000 usd
CY2023Q4 pro Treasury Money Market Funds At Fair Value
TreasuryMoneyMarketFundsAtFairValue
153200000 usd
CY2024Q1 us-gaap Revenue Recognition Customer Acquisitions
RevenueRecognitionCustomerAcquisitions
<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred costs</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales commissions earned by the Company's sales representatives are considered incremental and recoverable costs of obtaining a customer contract. Sales commissions are deferred and amortized on a straight-line basis over the period of benefit, which the Company has determined to be five to eight years. The Company determined the period of benefit by taking into consideration its customer contracts, expected renewals of those customer contracts (as the Company currently does not pay an incremental sales commission for renewals), the Company's technology and other factors. The Company also defers amounts earned by employees other than sales representatives who earn incentive payments under compensation plans also tied to the value of customer contracts acquired. Deferred costs were </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$14.5 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$15.1 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as of March 31, 2024 and December 31, 2023, respectively. Amortization expense for the deferred costs was </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.3 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $1.5 million for the three months ended March 31, 2024 and 2023, respectively. Amortization of deferred costs is included in </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">selling and marketing expense in the accompanying unaudited condensed consolidated statements of comprehensive loss.</span>
CY2024Q1 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
14500000 usd
CY2023Q4 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
15100000 usd
CY2024Q1 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
1300000 usd
CY2023Q1 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
1500000 usd
CY2024Q1 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
54500000 usd
CY2023Q1 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
49400000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
447600000 usd
CY2024Q1 pro Revenue Remaining Performance Obligationtoberecognizedwithin12months
RevenueRemainingPerformanceObligationtoberecognizedwithin12months
227400000 usd
CY2024Q1 us-gaap Revenues
Revenues
80688000 usd
CY2024Q1 pro Percentage Of Total Revenue
PercentageOfTotalRevenue
1
CY2023Q1 us-gaap Revenues
Revenues
73182000 usd
CY2023Q1 pro Percentage Of Total Revenue
PercentageOfTotalRevenue
1
CY2024Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P15Y
CY2024Q1 pro Lessee Operating Lease Termination Option
LesseeOperatingLeaseTerminationOption
P1Y
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
2233000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
2251000 usd
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2126000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2024Q1 pro Lease Modification Increase In Right Of Use Asset
LeaseModificationIncreaseInRightOfUseAsset
2100000 usd
CY2024Q1 pro Lease Modification Increase In Right Of Use Liability
LeaseModificationIncreaseInRightOfUseLiability
1400000 usd
CY2024Q1 pro Gain On Lease Modification
GainOnLeaseModification
700000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-800000 usd
CY2023Q1 pro Decrease In Right Of Use Asset And Related Lease Liability Due To Modification
DecreaseInRightOfUseAssetAndRelatedLeaseLiabilityDueToModification
1000000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
5738000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3923000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3895000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3796000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
3856000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
3912000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
14486000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
39606000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
8855000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
30751000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-19002000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46817000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45926000 shares
CY2024Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46817000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45926000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.24
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.24
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12700000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9904000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
100000000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y9M18D
CY2024Q1 pro Sharebasedcompensationarrangementbysharebasedpayment Minimum Employee Subscriptionrate
SharebasedcompensationarrangementbysharebasedpaymentMinimumEmployeeSubscriptionrate
0.01
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Maximum Employee Subscription Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate
0.10
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Discount From Market Price Offering Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate
0.15
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Discount From Market Price Offering Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate
0.15
CY2024Q1 pro Maximum Amount Contributablebyemployeesunder Espp Halfyearly
MaximumAmountContributablebyemployeesunderESPPHalfyearly
5000 usd
CY2024Q1 pro Maximum Amount Contributable By Employees Under Espp Annually
MaximumAmountContributableByEmployeesUnderESPPAnnually
10000 usd
CY2024Q1 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
40408 shares
CY2024Q1 pro Esp Pcontributionsby Employees
ESPPcontributionsbyEmployees
700000 usd
CY2024Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
288529000 usd
CY2024Q1 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
310700000 usd
CY2023Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
320500000 usd
CY2024Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
288529000 usd
CY2023Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
288529000 usd
CY2024Q1 us-gaap Debt Instrument Unamortized Premium
DebtInstrumentUnamortizedPremium
9100000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Premium
DebtInstrumentUnamortizedPremium
9776000 usd
CY2024Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
3990000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
4313000 usd
CY2024Q1 us-gaap Convertible Debt
ConvertibleDebt
293639000 usd
CY2023Q4 us-gaap Convertible Debt
ConvertibleDebt
293992000 usd
CY2024Q1 us-gaap Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
1555000 usd
CY2023Q1 us-gaap Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
1203000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
323000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
373000 usd
CY2024Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-676000 usd
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 usd
CY2024Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
1202000 usd
CY2023Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
1576000 usd
CY2023Q1 us-gaap Severance Costs1
SeveranceCosts1
3600000 usd
CY2023Q1 pro Cash Payments For Severance And Other Related
CashPaymentsForSeveranceAndOtherRelated
3200000 usd
CY2024Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1762000 usd
CY2023Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1730000 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-536000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-203000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-768000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-76000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
458000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1451000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-800000 usd
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001392972-24-000063-index-headers.html Edgar Link pending
0001392972-24-000063-index.html Edgar Link pending
0001392972-24-000063.txt Edgar Link pending
0001392972-24-000063-xbrl.zip Edgar Link pending
a2024q1ex311ceocertificati.htm Edgar Link pending
a2024q1ex312cfocertificati.htm Edgar Link pending
a2024q1ex321ceocfocertific.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pro-20240331.htm Edgar Link pending
pro-20240331.xsd Edgar Link pending
pro-20240331_g1.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
pro-20240331_cal.xml Edgar Link unprocessable
pro-20240331_def.xml Edgar Link unprocessable
pro-20240331_lab.xml Edgar Link unprocessable
pro-20240331_pre.xml Edgar Link unprocessable
pro-20240331_htm.xml Edgar Link completed